Final Results of a Single Arm Phase III Multicenter, Open-Label Study of Rituximab Administered by Faster Infusion in Patients with Previously Untreated Diffuse Large-B Cell (DLBCL) or Follicular Non-Hodgkin's Lymphoma (FL)

被引：0

作者：

Dakhil, Shaker R. ^{[1
]}

Hermann, Robert ^{[2
]}

Chai, Akiko ^{[3
]}

Hurst, Deborah

Fine, Gregg

Richards, Paul ^{[4
]}

机构：

[1] Canc Ctr Kansas, PA, Wichita, KS USA

[2] NW Georgia Oncol Ctr, Marietta, GA USA

[3] Genentech Inc, Biostat, San Francisco, CA 94080 USA

[4] Blue Ridge Canc Care, Salem, VA USA

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1162 / 1163

页数：2